|
[1]
|
Koye, D., Magliano, D., Nelson, R., et al. (2018) The Global Epidemiology of Diabetes and Kidney Disease. Advances in Chronic Kidney Disease, 25, 121-132. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
American Diabetes Association (2020) Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2020. Diabetes Care, 43, S135-S151.
|
|
[3]
|
Cheng, H., Xu, X., Lim, P., et al. (2021) Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000-2015. Diabetes Care, 44, 89-97. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
中国2型糖尿病防治指南(2020年版) (下) [J]. 中国实用内科杂志, 2021, 41(9): 757-784.
|
|
[5]
|
Mogensen, C., Christensen, C. and Vittinghus, E. (1983) The Stages in Diabetic Renal Disease. With Emphasis on the Stage of Incipient Diabetic Nephropathy. Diabetes, 32, 64-78. [Google Scholar] [CrossRef]
|
|
[6]
|
Oshima, M., Shimizu, M., Yamanouchi, M., et al. (2021) Trajectories of Kidney Function in Diabetes: A Clinicopathological Update. Nature Reviews Nephrology, 17, 740-750. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Ketteler, M. and Ambühl, P. (2021) Where Are We Now? Emerging Opportunities and Challenges in the Management of Secondary Hyperparathyroidism in Patients with Non-Dialysis Chronic Kidney Disease. Journal of Nephrology, 34, 1405-1418. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Bargagli, M., Arena, M., Naticchia, A., et al. (2021) The Role of Diet in Bone and Mineral Metabolism and Secondary Hyperparathyroidism. Nutrients, 13, 2328. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
González, E., Sachdeva, A., Oliver, D., et al. (2004) Vitamin D Insufficiency and Deficiency in Chronic Kidney Disease. A Single Center Observational Study. American Journal of Nephrology, 24, 503-510. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Kuro, O. (2012) Klotho in Health and Disease. Current Opinion in Nephrology and Hypertension, 21, 362-368. [Google Scholar] [CrossRef]
|
|
[11]
|
Choi, B., Kim, C., Lim, Y., et al. (2010) Transcriptional Activation of the Human Klotho Gene by Epidermal Growth Factor in HEK293 Cells; Role of Egr-1. Gene, 450, 121-127. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Cunningham, J., Locatelli, F. and Rodriguez, M. (2011) Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options. Journal of the American Society of Nephrology, 6, 913-921. [Google Scholar] [CrossRef]
|
|
[13]
|
Da Costa, A., Pellizzari, C., Carvalho, G., et al. (2016) High Prevalence of Subclinical Hypothyroidism and Nodular Thyroid Disease in Patients on Hemodialysis. Hemodialysis International, 20, 31-37. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Kaptein, E. (1996) Thyroid Hormone Metabolism and Thyroid Diseases in Chronic Renal Failure. Endocrine Reviews, 17, 45-63. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Sanai, T., Okamura, K., Kishi, T., et al. (2015) Importance of Specific Reference Values for Evaluation of the Deteriorating Thyroid Function in Patients with End-Stage Renal Disease on Hemodialysis. Journal of Endocrinological Investigation, 38, 47-56. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Zhao, W., Li, X., Liu, X., et al. (2018) Thyroid Function in Patients with Type 2 Diabetes Mellitus and Diabetic Nephropathy: A Single Center Study. Journal of Thyroid Research, 2018, Article ID: 9507028. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Fei, X., Xing, M., Wo, M., et al. (2018) Thyroid Stimulating Hormone and Free Triiodothyronine Are Valuable Predictors for Diabetic Nephropathy in Patient with Type 2 Diabetes Mellitus. Annals of Translational Medicine, 6, 305. [Google Scholar] [CrossRef] [PubMed]
|